Showing results (261-270 of 285) with videos related to

Sort By:
Pageof 29
Contemporary Clinical Trials Communications|April 27, 2018
Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trialT van Doeveren, P J van Leeuwen, K K H Aben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer MicroenvironmentMaksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
World Journal of Urology|August 16, 2018
ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancerLeonardo L Monteiro, J Alfred Witjes, Piyush K Agarwal, et al.
International Journal of Cancer|October 2, 2020
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladderThomas van Doeveren, Jose A Nakauma-Gonzalez, Andrew S Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.
Nature Medicine|February 2, 2023
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trialJeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann, et al.
Pageof 29